Selected research
Market Structure
Global Laxatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Laxatives market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Laxatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Laxatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Laxatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Laxatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Laxatives include Abbott Laboratories, Boehringer Ingelheim, Braintree Laboratories, Purdue Pharma, Sucampo Pharmaceuticals, AstraZeneca, Bayer, GlaxoSmithKline and Takeda Pharmaceutical Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Laxatives market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Laxatives and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Laxatives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Laxatives market size, projected growth trends, production technologies, key applications, and end-use industries.
Laxatives Segment by Company
Abbott Laboratories
Boehringer Ingelheim
Braintree Laboratories
Purdue Pharma
Sucampo Pharmaceuticals
AstraZeneca
Bayer
GlaxoSmithKline
Takeda Pharmaceutical Company
Laxatives Segment by Type
Lubricating Laxative
Volumetric Laxative
Swelling Laxative
Hypertonic Laxative
Stimulant Laxative
Others
Laxatives Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Laxatives Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laxatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Laxatives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laxatives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Laxatives market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Laxatives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Laxatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Laxatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Lubricating Laxative
- Volumetric Laxative
- Swelling Laxative
- Hypertonic Laxative
- Stimulant Laxative
- Others
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Abbott Laboratories
- Boehringer Ingelheim
- Braintree Laboratories
- Purdue Pharma
- Sucampo Pharmaceuticals
- AstraZeneca
- Bayer
- GlaxoSmithKline
- Takeda Pharmaceutical Company
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Laxatives Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Laxatives Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Laxatives Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Laxatives Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Laxatives Market Dynamics
- 2.1 Laxatives Industry Trends
- 2.2 Laxatives Industry Drivers
- 2.3 Laxatives Industry Opportunities and Challenges
- 2.4 Laxatives Industry Restraints
3 Laxatives Market by Manufacturers
- 3.1 Global Laxatives Revenue by Manufacturers (2021-2026)
- 3.2 Global Laxatives Sales by Manufacturers (2021-2026)
- 3.3 Global Laxatives Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Laxatives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Laxatives Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Laxatives Manufacturers, Product Type & Application
- 3.7 Global Laxatives Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Laxatives Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Laxatives Players Market Share by Revenue in 2025
- 3.8.3 2025 Laxatives Tier 1, Tier 2, and Tier 3
4 Laxatives Market by Type
- 4.1 Laxatives Type Introduction
- 4.1.1 Lubricating Laxative
- 4.1.2 Volumetric Laxative
- 4.1.3 Swelling Laxative
- 4.1.4 Hypertonic Laxative
- 4.1.5 Stimulant Laxative
- 4.1.6 Others
- 4.2 Global Laxatives Sales by Type
- 4.2.1 Global Laxatives Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Laxatives Sales by Type (2021-2032)
- 4.2.3 Global Laxatives Sales Market Share by Type (2021-2032)
- 4.3 Global Laxatives Revenue by Type
- 4.3.1 Global Laxatives Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Laxatives Revenue by Type (2021-2032)
- 4.3.3 Global Laxatives Revenue Market Share by Type (2021-2032)
5 Laxatives Market by Application
- 5.1 Laxatives Application Introduction
- 5.1.1 Hospital Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Retail Pharmacies
- 5.2 Global Laxatives Sales by Application
- 5.2.1 Global Laxatives Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Laxatives Sales by Application (2021-2032)
- 5.2.3 Global Laxatives Sales Market Share by Application (2021-2032)
- 5.3 Global Laxatives Revenue by Application
- 5.3.1 Global Laxatives Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Laxatives Revenue by Application (2021-2032)
- 5.3.3 Global Laxatives Revenue Market Share by Application (2021-2032)
6 Global Laxatives Sales by Region
- 6.1 Global Laxatives Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Laxatives Sales by Region (2021-2032)
- 6.2.1 Global Laxatives Sales by Region (2021-2026)
- 6.2.2 Global Laxatives Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Laxatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Laxatives Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Laxatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Laxatives Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Laxatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Laxatives Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Laxatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Laxatives Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Laxatives Revenue by Region
- 7.1 Global Laxatives Revenue by Region
- 7.1.1 Global Laxatives Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Laxatives Revenue by Region (2021-2026)
- 7.1.3 Global Laxatives Revenue by Region (2027-2032)
- 7.1.4 Global Laxatives Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Laxatives Revenue (2021-2032)
- 7.2.2 North America Laxatives Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Laxatives Revenue (2021-2032)
- 7.3.2 Europe Laxatives Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Laxatives Revenue (2021-2032)
- 7.4.2 Asia-Pacific Laxatives Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Laxatives Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Laxatives Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Abbott Laboratories
- 8.1.1 Abbott Laboratories Company Information
- 8.1.2 Abbott Laboratories Business Overview
- 8.1.3 Abbott Laboratories Laxatives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Abbott Laboratories Laxatives Product Portfolio
- 8.1.5 Abbott Laboratories Recent Developments
- 8.2 Boehringer Ingelheim
- 8.2.1 Boehringer Ingelheim Company Information
- 8.2.2 Boehringer Ingelheim Business Overview
- 8.2.3 Boehringer Ingelheim Laxatives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Boehringer Ingelheim Laxatives Product Portfolio
- 8.2.5 Boehringer Ingelheim Recent Developments
- 8.3 Braintree Laboratories
- 8.3.1 Braintree Laboratories Company Information
- 8.3.2 Braintree Laboratories Business Overview
- 8.3.3 Braintree Laboratories Laxatives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Braintree Laboratories Laxatives Product Portfolio
- 8.3.5 Braintree Laboratories Recent Developments
- 8.4 Purdue Pharma
- 8.4.1 Purdue Pharma Company Information
- 8.4.2 Purdue Pharma Business Overview
- 8.4.3 Purdue Pharma Laxatives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Purdue Pharma Laxatives Product Portfolio
- 8.4.5 Purdue Pharma Recent Developments
- 8.5 Sucampo Pharmaceuticals
- 8.5.1 Sucampo Pharmaceuticals Company Information
- 8.5.2 Sucampo Pharmaceuticals Business Overview
- 8.5.3 Sucampo Pharmaceuticals Laxatives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Sucampo Pharmaceuticals Laxatives Product Portfolio
- 8.5.5 Sucampo Pharmaceuticals Recent Developments
- 8.6 AstraZeneca
- 8.6.1 AstraZeneca Company Information
- 8.6.2 AstraZeneca Business Overview
- 8.6.3 AstraZeneca Laxatives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 AstraZeneca Laxatives Product Portfolio
- 8.6.5 AstraZeneca Recent Developments
- 8.7 Bayer
- 8.7.1 Bayer Company Information
- 8.7.2 Bayer Business Overview
- 8.7.3 Bayer Laxatives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Bayer Laxatives Product Portfolio
- 8.7.5 Bayer Recent Developments
- 8.8 GlaxoSmithKline
- 8.8.1 GlaxoSmithKline Company Information
- 8.8.2 GlaxoSmithKline Business Overview
- 8.8.3 GlaxoSmithKline Laxatives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 GlaxoSmithKline Laxatives Product Portfolio
- 8.8.5 GlaxoSmithKline Recent Developments
- 8.9 Takeda Pharmaceutical Company
- 8.9.1 Takeda Pharmaceutical Company Company Information
- 8.9.2 Takeda Pharmaceutical Company Business Overview
- 8.9.3 Takeda Pharmaceutical Company Laxatives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Takeda Pharmaceutical Company Laxatives Product Portfolio
- 8.9.5 Takeda Pharmaceutical Company Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Laxatives Value Chain Analysis
- 9.1.1 Laxatives Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Laxatives Production Mode & Process
- 9.2 Laxatives Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Laxatives Distributors
- 9.2.3 Laxatives Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst